Medicine & Life Sciences
Glioblastoma
100%
Immunotherapy
56%
Glioma
56%
Brain Neoplasms
44%
Neoplasms
31%
Craniotomy
30%
T-Lymphocytes
27%
Subarachnoid Hemorrhage
24%
Length of Stay
24%
Survival
22%
Frailty
20%
Therapeutics
18%
Meningioma
17%
Radiosurgery
17%
Aneurysm
17%
Trigeminal Neuralgia
16%
STAT3 Transcription Factor
14%
Microvascular Decompression Surgery
14%
Tumor Microenvironment
14%
Immunosuppression
13%
Radiation
13%
Patient Readmission
13%
Brain
13%
Programmed Cell Death 1 Receptor
13%
Immunosuppressive Agents
13%
Radiotherapy
11%
Neoplasm Metastasis
11%
Subdural Hematoma
11%
Clinical Trials
11%
Chimeric Antigen Receptors
11%
Ruptured Aneurysm
11%
Central Nervous System Neoplasms
11%
Central Nervous System
10%
Hospital Charges
10%
Intracranial Aneurysm
9%
Immunity
9%
Melanoma
9%
Dendritic Cells
9%
Rupture
9%
Hematoma, Subdural, Acute
9%
Systematic Reviews
9%
Skull Base
9%
Regulatory T-Lymphocytes
9%
Mortality
8%
Karnofsky Performance Status
8%
Transcriptional Activation
8%
Myeloid Cells
8%
Microglia
7%
Lateral Sinus Thrombosis
7%
Mucin-3
7%